The Coagulation Medicine Fellowship is a 1-year program located at the UC San Diego Health Center for Bleeding and Clotting Disorders (CBCD). The CBCD is federally designated and receiving support from the American Thrombosis and Hemostasis Network and from the Centers for Disease Control and Prevention. We provide comprehensive, multi-disciplinary care for patients with hemophilia and congenital bleeding and clotting disorders. The CBCD also includes a Center of Excellence for Hereditary Hemorrhagic Telenagiectasia (HHT).
The fellowship program was designed to provide specialized training in diagnosing and managing congenital and acquired bleeding and thrombotic disorders. The congenital program includes patients with hemophilia, von Willebrand disease, inherited platelet function disorders, rare factor deficiencies, hereditary hemorrhagic telangiectasia, as well as inherited venous and arterial thrombotic disorders. Examples of acquired conditions include immune thrombocytopenic purpura, microangiopathies, antiphospholipid syndrome, and other etiologies of thromboembolism.
The program also entails a combined clinic with Gynecology for women with bleeding disorders.
Clinical
The Fellow will assume care responsibilities in outpatient clinics, participate in weekly didactic sessions, and support inpatient management plans in close communication with the inpatient Hematology consult service. The Fellow also has the opportunity to take part in community outreach programs such as Hemophilia walks and camps, as well as experience patient advocacy activities.
Research
The Fellowship provides the opportunity to participate in and develop innovative research ideas in the area of hemostasis and thrombosis. There are numerous research projects, including federally and industry-sponsored basic research, industry-sponsored clinical trials (e.g., gene therapy in hemophilia), and CBCD-based projects. Such clinical and translational projects mostly focus on improving outcomes for patients with hemophilia and other congenital bleeding and clotting disorders. Examples are the advancement of joint health and the application of musculoskeletal ultrasound in hemophilia care, utilization of in-clinic point-of-care ultrasound for management of venous thromboembolism, or impact of post-partum hemorrhage on maternal outcomes.
Basic research opportunities include molecular aspects of the progression of hemophilic arthropathy using innovative technologies such as proteomics and RNAseq in mice and patient cohorts, effects of iron deficiency anemia on bleeding propensity during trauma and post-partum-hemorrhage.
CBCD-based programs of note include a cutting-edge CME-accredited training course in Musculoskeletal Ultrasound and the possibility of training in point-of-care vascular ultrasound for DVT imaging. For Fellows interested in Global Hematology, there are opportunities to engage in international outreach and clinical research, specifically at our partner site in Maputo, Mozambique.
Depending upon progress, the Fellowship can be extended for an additional year.
